Global Antimicrobial Susceptibility Testing Market Analysis, Application, And Forecast To 2027Posted by Karthik Pilla on March 28th, 2023 Bharat Book Bureau Provides the Trending Market Research Report on “Antimicrobial Susceptibility Testing Market by Product (Manual, Automated), Type (Antibacterial, Antifungal), Application (Clinical Diagnostics), Method (ETEST, Disk Diffusion, Agar Diffusion, Genotyping), End User & Region - Global Forecasts to 2027” under the Life Sciences Market Research Report Category. The report offers a collection of superior Market research, Market analysis, competitive intelligence, and Market reports.
The Antimicrobial Susceptibility Testing Market is projected to reach USD 4.7 billion by 2027 from USD 3.6 billion in 2022, at a CAGR of 5.5% during the forecast period. The significant growth of the antimicrobial susceptibility testing market is largely due to the overuse and misuse of antibiotics, which resuresistance microbial resistances (AMR), and the increased use of antimicrobial susceptibility testing by biopharmaceutical, biotechnological, and pharmaceutical companies. Automated laboratory instruments holds the largest market share in 2022. Automated identification and susceptibility systems are more expensive than manual conventional ones but offer the advantage of quicker findings. Although automated methods are more efficient and of higher quality, some bacteria and antimicrobial agents have specific technological limitations. “The Antibacterial infections is holding the largest share of the market in 2022” Based on type, the antimicrobial susceptibility testing market is classified into antibacterial susceptibility testing, antifungal susceptibility testing, antiparasitic susceptibility testing and other susceptibility testing. The large share of this segment is attributed to the presence of regulatory guidelines to streamline the process of antibacterial susceptibility testing, technological advancements in this segment, and the rising burden of antibacterial resistance in developing and developed countries. “The market in North America region is expected to witness the highest growth during the forecast period.” North America accounted for the largest market share—35.4%—in 2022. The increasing R&D to develop novel automated AST systems, rising prevalence of infectious diseases, growing safety concerns, and technological advancements in antimicrobial susceptibility testing products are the key factors supporting market growth in North America A breakdown of the primary participants referred to for this report is provided below: The prominent player in Antimicrobial susceptibility testing are bioMérieux SA (France), Becton, Dickinson and Company (US), Thermo Fisher Scientific (US), Danaher Corporation (US), Bio-Rad Laboratories, Inc. (US) Research Coverage Reasons to Buy the Report This report provides insights on the following pointers:
Browse our full report with Table of Content:
About Bharat Book Bureau:
Contact us at: Like it? Share it!More by this author |